In spite of its shortcomings, The point that the coverage is currently being rolled out like a demo can be a constructive point, reckons Michel Kazatchkine, a member of the worldwide Commission on Drug Coverage. The strongest way to persuade naysayers is thru providing cold, really hard, irrefutable proof, he claims, and The easiest method to do th